FAM207CP

Across TCGA pan-cancer cohorts, FAM207CP RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated FAM207CP data layer.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where higher FAM207CP RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated FAM207CP expression acts as an unfavorable survival marker.

PAAD, UCEC, and DLBC are the cancer types where FAM207CP RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PAAD	DFS	Tertile	All	0.098	0.505	.002	72	view →
UCEC	DFS	Tertile	All	0.511	0.840	.001	66	view →
DLBC	DFS	Tertile	II,III,IV	0.097	0.834	<.001	36	view →
KIRC	DFS	Tertile	III,IV	0.217	0.743	.013	36	view →
LUAD	OS	Tertile	II,III,IV	0.113	0.677	.001	30	view →
ACC	DFS	Tertile	All	0.207	0.658	.016	27	view →
SKCM	OS	Tertile	All	0.106	0.401	.009	15	view →
KIRP	OS	Tertile	All	0.680	0.948	.039	12	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →
UVM	OS	Tertile	III,IV	0.220	0.872	.025	9	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

FAM207CP–PAAD (DFS)

Open the PAAD breakdown →